Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
Clark RA, Portnoy A, Weerasuriya CK, Sumner T, Bakker R, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Clark RA, et al. Among authors: mattoo sk. medRxiv [Preprint]. 2023 Sep 27:2023.09.27.23296211. doi: 10.1101/2023.09.27.23296211. medRxiv. 2023. PMID: 37808744 Free PMC article. Preprint.
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.
Clark RA, Weerasuriya CK, Portnoy A, Mukandavire C, Quaife M, Bakker R, Scarponi D, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. Clark RA, et al. Among authors: mattoo sk. medRxiv [Preprint]. 2023 Jul 10:2023.02.24.23286406. doi: 10.1101/2023.02.24.23286406. medRxiv. 2023. Update in: BMC Med. 2023 Aug 4;21(1):288. doi: 10.1186/s12916-023-02992-7 PMID: 36865172 Free PMC article. Updated. Preprint.
Quality of active case-finding for tuberculosis in India: a national level secondary data analysis.
Shewade HD, Kiruthika G, Ravichandran P, Iyer S, Chowdhury A, Kiran Pradeep S, Jeyashree K, Devika S, Chadwick J, Wesley Vivian J, Tumu D, Shah AN, Vadera B, Roddawar V, Mattoo SK, Rade K, Rao R, Murhekar MV. Shewade HD, et al. Among authors: mattoo sk. Glob Health Action. 2023 Dec 31;16(1):2256129. doi: 10.1080/16549716.2023.2256129. Epub 2023 Sep 21. Glob Health Action. 2023. PMID: 37732993 Free PMC article.
Bridging the "know-do" gap to improve active case finding for tuberculosis in India: A qualitative exploration into national tuberculosis elimination program staffs' perspectives.
Shewade HD, Ravichandran P, Pradeep SK, Kiruthika G, Shanmugasundaram D, Chadwick J, Iyer S, Chowdhury A, Tumu D, Shah AN, Vadera B, Roddawar V, Mattoo SK, Rade K, Rao R, Murhekar MV. Shewade HD, et al. Among authors: mattoo sk. PLoS One. 2024 Nov 4;19(11):e0309750. doi: 10.1371/journal.pone.0309750. eCollection 2024. PLoS One. 2024. PMID: 39495760 Free PMC article.
Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
de Villiers AK, Osman M, Struchiner CJ, Trajman A, Tumu D, Shah VV, Werneck GL, Alves LC, Choudhary M, Verma S, Mattoo SK, Meehan SA, Singh UB, Hesseling AC, Marx FM. de Villiers AK, et al. Among authors: mattoo sk. PLOS Glob Public Health. 2025 Jan 7;5(1):e0003309. doi: 10.1371/journal.pgph.0003309. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 39774490 Free PMC article.
Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV-India.
Agarwal R, Agarwal U, Das C, Reddy RA, Pant R, Ho C, Kumar BR, Dabla V, Moonan PK, Nyendak M, Anand S, Puri AK, Mattoo SK, Sachdeva KS, Yeldandi VV, Sarin R. Agarwal R, et al. Among authors: mattoo sk. BMC Infect Dis. 2022 Dec 29;22(1):967. doi: 10.1186/s12879-022-07957-4. BMC Infect Dis. 2022. PMID: 36581907 Free PMC article. Review.
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocol.
Padmapriyadarsini C, Devaleenal B, Ponnuraja C, Ramraj B, Singla R, Parmar M, Mattoo S, Mandal S. Padmapriyadarsini C, et al. BMJ Open. 2022 Aug 29;12(8):e058606. doi: 10.1136/bmjopen-2021-058606. BMJ Open. 2022. PMID: 36038181 Free PMC article.
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Among authors: mattoo sk. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
180 results